Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions.
about
Psychostimulants and cognition: a continuum of behavioral and cognitive activationCardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: focus on clinical efficacy and safety.Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples.Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.ADHD treatments, sleep, and sleep problems: complex associationsAdvanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine EffectsPerformance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatmentsEfficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorderComparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysisOsmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder.Interventions for executive function deficits in children and adolescents.A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update.The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research.Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.Atomoxetine treatment for children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD): a comprehensive meta-analysis of outcomes on parent-rated core symptomatology.Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder.Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults.The effects of methylphenidate on whole brain intrinsic functional connectivity.Increased prefrontal hemodynamic change after atomoxetine administration in pediatric attention-deficit/hyperactivity disorder as measured by near-infrared spectroscopy.Differential long-term medication impact on executive function and delay aversion in ADHD.Dynamic growth and yield model for Black pine stands in SpainThe Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression
P2860
Q22242285-84CB8677-6A64-4A91-8FDA-F9CC4DB2A93CQ30399107-431E6598-3E36-40F3-B80F-AA283C61150BQ30593927-63A613C0-F70C-4641-BE7B-9BE81218B386Q34072167-C8946A0C-899B-4822-9342-D8E8503FDE5CQ34139721-A48B90C1-28EC-40EE-9F17-2B303A8B6587Q34744662-71B58196-3862-4182-951E-E1E7618DC07EQ36233163-28E8C364-7694-47A7-83F0-EE5617D1921AQ36514345-5DC0627A-907A-4F83-9A98-541AF8170B60Q36681100-8A92AAB4-3B93-404B-A3BE-F02565C01702Q36751226-E646E77F-4506-48C5-84E4-B407198BEDD0Q36983210-6B2369BB-ED68-4C69-84AC-AD34D60DBB00Q37184589-9202D3ED-BE73-4317-92D8-CE2855F639A9Q38121124-85F8DA65-1A3C-40C7-927B-437632981B72Q38239633-3656DD26-5691-4F99-9314-E14A8441365EQ38240014-35301F69-F6AF-4B43-9FD0-C02C96A7B37DQ38362252-C67E2EA7-76FD-4420-B91D-B83B4A7F3CCCQ38862420-DF2451B2-44BD-438F-829E-A87D45DD874DQ39040595-929DFE9B-0032-4EE2-AB98-A6CB7046B37FQ39097761-A96AF3F9-13B3-4DAB-A471-503C4362D6E6Q46584563-56F088BF-69F7-4E74-9F30-632C6BD65756Q46584948-D192967C-52B9-4716-956D-69AA861D8A84Q48287168-3C467C33-8698-4D1A-8BB5-D958133BA3A9Q48469834-B110A29B-3E06-4F6B-AA5C-9B8E8D973391Q49821724-A06557BA-EB4C-4118-8D78-74F1B3CBB128Q57536079-1D98C4D1-01D5-4DD0-9EF6-95CEFD6CADABQ58734154-FB1EBD92-7DA0-4884-B84F-3EFF2F1CA5CB
P2860
Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Atomoxetine and methylphenidat ...... ffects on executive functions.
@en
Atomoxetine and methylphenidat ...... ffects on executive functions.
@nl
type
label
Atomoxetine and methylphenidat ...... ffects on executive functions.
@en
Atomoxetine and methylphenidat ...... ffects on executive functions.
@nl
prefLabel
Atomoxetine and methylphenidat ...... ffects on executive functions.
@en
Atomoxetine and methylphenidat ...... ffects on executive functions.
@nl
P2093
P2860
P1476
Atomoxetine and methylphenidat ...... ffects on executive functions.
@en
P2093
Belma Agaoglu
Isik Karakaya
Nursu Cakin Memik
Ozlem Yildiz
Sahika G Sismanlar
P2860
P2888
P304
P356
10.1007/S10578-010-0212-3
P577
2011-06-01T00:00:00Z